ArticleCommunications biology2026
Structure and potential role of T6SS effector PdpC in Francisella tularensis intracellular lifestyle.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Francisella tularensis, a gram-negative facultative intracellular pathogen, causes the often-fatal disease tularemia. Its Francisella pathogenicity island (FPI) encodes a type VI secretion system (T6SS) critical for virulence, yet the mechanisms by which T6SS effectors enable intracellular replication remain poorly understood. Here, we report the structure of the T6SS effector PdpC, revealing a novel protein fold with no identifiable homologs. The structure resembles a seahorse, comprising five domains: an N-terminal domain, a central body domain (CBD), a wedge domain, a C-terminal tail, and an unmodeled "mouth" domain. Biochemical analyses demonstrate that PdpC binds host phospholipids, particularly phosphatidylinositol-3-phosphate, and interacts with PdpE, another FPI-encoded protein. Structure-guided functional studies show that the CBD alone suffices for these interactions, while PdpE is secreted via a T6SS-independent pathway. These findings explain how the sophisticated effector duo enables phagosomal escape and establishes infection: PdpC is delivered by T6SS to PI(3)P-enriched early phagosomal membranes to rupture phagosomes to escape, and then coordinates with PdpE to promote intracytoplasmic Francisella replication. This work transforms PdpC from an orphan virulence factor into a tractable molecular switch at the heart of Francisella's intracellular lifestyle and a potential target for anti-tularemia therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.